{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:45:10Z","timestamp":1790959510452,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.phymed.2022.154587","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:46:36Z","timestamp":1670255196000},"page":"154587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-\u03b3\/STAT1\/Smad7 pathway"],"prefix":"10.1016","volume":"112","author":[{"given":"Manman","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongda","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinya","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2022.154587_bib0001","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2014.01.022","article-title":"Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo","volume":"179","author":"Bansal","year":"2014","journal-title":"J. Control Release"},{"key":"10.1016\/j.phymed.2022.154587_bib0002","article-title":"Cellular and molecular mechanisms underlying liver fibrosis regression","volume":"10","author":"Caligiuri","year":"2021","journal-title":"Cells-Basel"},{"key":"10.1016\/j.phymed.2022.154587_bib0003","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/liv.14940","article-title":"Hepatic macrophages: Key players in the development and progression of liver fibrosis","volume":"41","author":"Cheng","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.phymed.2022.154587_bib0004","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cbi.2018.12.006","article-title":"Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-beta1\/Smad and NOX4\/ROS pathways","volume":"299","author":"Cheng","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.phymed.2022.154587_bib0005","doi-asserted-by":"crossref","first-page":"47313","DOI":"10.1021\/acsami.1c08107","article-title":"Dual-Functional dendrimer micelles with glycyrrhizic acid for anti-inflammatory therapy of acute lung injury","volume":"13","author":"Choi","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.phymed.2022.154587_bib0006","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1535370219898141","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar","year":"2020","journal-title":"Exp. Biol. Med. (Maywood, N.J.)"},{"key":"10.1016\/j.phymed.2022.154587_bib0007","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2131\/jts.41.561","article-title":"Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis","volume":"41","author":"Dong","year":"2016","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.phymed.2022.154587_bib0008","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1038\/d41586-018-07759-2","article-title":"Liver cirrhosis: scar wars","volume":"564","author":"Drew","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2022.154587_bib0009","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.4252\/wjsc.v13.i10.1580","article-title":"Effect of glycyrrhizic acid and 18beta-glycyrrhetinic acid on the differentiation of human umbilical cord-mesenchymal stem cells into hepatocytes","volume":"13","author":"Fatima","year":"2021","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.phymed.2022.154587_bib0010","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3748\/wjg.v19.i24.3781","article-title":"Glycyrrhizic acid attenuates CCl\u2084-induced hepatocyte apoptosis in rats via a p53-mediated pathway","volume":"19","author":"Guo","year":"2013","journal-title":"World J. Gastroentero."},{"key":"10.1016\/j.phymed.2022.154587_bib0011","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bioorg.2019.02.037","article-title":"Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenase","volume":"87","author":"Guo","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.phymed.2022.154587_bib0012","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.phymed.2022.154587_bib0013","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.phymed.2022.154587_bib0014","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","article-title":"New insights into TGF-beta\/Smad signaling in tissue fibrosis","volume":"292","author":"Hu","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.phymed.2022.154587_bib0015","article-title":"Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFbeta signalling","author":"Hung","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.phymed.2022.154587_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109354","article-title":"Hepatoprotective effect of different combinations of 18\u03b1-and 18\u03b2-Glycyrrhizic acid against CCl(4)-induced liver injury in rats","volume":"122","author":"Huo","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2022.154587_bib0017","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gutjnl-2016-312473","article-title":"Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal","volume":"66","author":"Ikenaga","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.phymed.2022.154587_bib0018","first-page":"890","article-title":"Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice","volume":"38","author":"Inagaki","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2022.154587_bib0019","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2022.154587_bib0020","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.arr.2012.02.007","article-title":"The role of CUGBP1 in age-dependent changes of liver functions","volume":"11","author":"Jones","year":"2012","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.phymed.2022.154587_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112442","article-title":"Advances in anti-hepatic fibrotic therapy with traditional Chinese medicine herbal formula","volume":"251","author":"Li","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2022.154587_bib0022","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.phrs.2019.04.025","article-title":"Natural products in licorice for the therapy of liver diseases: progress and future opportunities","volume":"144","author":"Li","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2022.154587_bib0023","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.3748\/wjg.v21.i17.5271","article-title":"Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury","volume":"21","author":"Liang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phymed.2022.154587_bib0024","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6175091","article-title":"Isorhamnetin inhibits liver fibrosis by reducing autophagy and inhibiting extracellular matrix formation via the TGF-beta1\/Smad3 and TGF-beta1\/p38 MAPK pathways","volume":"2019","author":"Liu","year":"2019","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.phymed.2022.154587_bib0025","doi-asserted-by":"crossref","first-page":"9357","DOI":"10.1080\/21655979.2022.2054224","article-title":"Guizhi Fuling pill attenuates liver fibrosis in vitro and in vivo via inhibiting TGF-beta1\/Smad2\/3 and activating IFN-gamma\/Smad7 signaling pathways","volume":"13","author":"Liu","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.phymed.2022.154587_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211123","article-title":"IL-11 prevents IFN-gamma-induced hepatocyte death through selective downregulation of IFN-gamma\/STAT1 signaling and ROS scavenging","volume":"14","author":"Miyawaki","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phymed.2022.154587_bib0027","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022095","article-title":"Regulation of TGF-beta family signaling by inhibitory smads","volume":"9","author":"Miyazawa","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.phymed.2022.154587_bib0028","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2893.2005.00689.x","article-title":"Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection","volume":"13","author":"Muir","year":"2006","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.phymed.2022.154587_bib0029","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/hep.30083","article-title":"Diabetes, plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer: a prospective study of 0.5 million people","volume":"68","author":"Pang","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2022.154587_bib0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.4733","article-title":"Enhanced protection from fibrosis and inflammation in the combined absence of IL-13 and IFN-gamma","volume":"239","author":"Ramalingam","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.phymed.2022.154587_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041145","article-title":"CD147 promotes CXCL1 expression and modulates liver fibrogenesis","volume":"19","author":"Shi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2022.154587_bib0032","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1136\/gutjnl-2018-317872","article-title":"Glial cell line-derived neurotrophic factor (GDNF) mediates hepatic stellate cell activation via ALK5\/Smad signalling","volume":"68","author":"Tao","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.phymed.2022.154587_bib0033","first-page":"99","article-title":"Isolation and culture of hepatic stellate cells","volume":"117","author":"Weiskirchen","year":"2005","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.phymed.2022.154587_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107151","article-title":"Amygdalin inhibits TGF\u03b21-induced activation of hepatic stellate cells (HSCs) in vitro and CCl(4)-induced hepatic fibrosis in rats in vivo","volume":"90","author":"Wang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2022.154587_bib0035","doi-asserted-by":"crossref","first-page":"13498","DOI":"10.1038\/ncomms13498","article-title":"CUG-binding protein 1 regulates HSC activation and liver fibrogenesis","volume":"7","author":"Wu","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2022.154587_bib0036","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1053\/j.gastro.2019.05.066","article-title":"Aryl hydrocarbon receptor signaling prevents activation of hepatic stellate cells and liver fibrogenesis in mice","volume":"157","author":"Yan","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2022.154587_bib0037","doi-asserted-by":"crossref","first-page":"44910","DOI":"10.1038\/srep44910","article-title":"Quantitative proteomic analysis on activated hepatic stellate cells reversion reveal STAT1 as a key regulator between liver fibrosis and recovery","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2022.154587_bib0038","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/tox.22878","article-title":"TGF-\u03b21 mediated Smad signaling pathway and EMT in hepatic fibrosis induced by Nano NiO in vivo and in vitro","volume":"35","author":"Zhang","year":"2020","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.phymed.2022.154587_bib0039","article-title":"Glycyrrhizic acid for COVID-19: findings of targeting pivotal inflammatory pathways triggered by SARS-CoV-2","volume":"12","author":"Zheng","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711322006754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711322006754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:45:51Z","timestamp":1760553951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711322006754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":39,"alternative-id":["S0944711322006754"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2022.154587","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-\u03b3\/STAT1\/Smad7 pathway","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2022.154587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154587"}}